Bitmine Ether holdings surge as chairman pushes expansion plan
Bitmine has boosted its Ether holdings again as its chairman seeks approval to expand the firm’s crypto treasury and staking plans.
Isaac Francis
Finance JournalistFinance journalist at Grafa. Covers tech, crypto, and markets, making complex finance clear for all. Passionate about innovation and trends.
Articles by Isaac Francis
Cryptocurrency
Trump urges tech firms to cover soaring data centre power costs
Donald Trump has called on technology giants to absorb rising data centre power costs to protect US consumers.
Government
India and US remain engaged in trade talks ambassador says
India and the United States remain in active talks to reach a long-delayed trade agreement, according to Washington’s new envoy.
-640x358.jpg&w=3840&q=75)
Cryptocurrency
Polygon CEO highlights POL benefits as active users decline
Polygon’s CEO says POL holders gain from burns and staking even as active users on the network decline.
-640x358.jpg&w=3840&q=75)
Cryptocurrency
VelaFi raises $20M to expand stablecoin settlement services
VelaFi has secured $20m in new funding to grow its stablecoin-based settlement and enterprise payment services worldwide.
Trump imposes 25% tariff on countries trading with Iran
President Donald Trump has imposed a sweeping 25% tariff on countries trading with Iran as protests grip the country.
Apple turns to Google’s Gemini after AI setback
Apple is shifting its AI strategy by adopting Google’s Gemini models after its own Apple Intelligence platform fell short.
Mining
Osmond Resources to fast-track high-grade zone at Orión Project
Osmond Resources (ASX:OSM) announced plans to accelerate development of the high-grade zone at its flagship Orión EU Critical Minerals Project.
Oil and Gas
Horizon Oil greenlights Nam Phong Booster Compressor Project
Horizon Oil (ASX:HZN) announced that the Nam Phong joint venture has reached a final investment decision for the Nam Phong Booster Compressor Project.
Health
LTR Pharma begins Phase 2 trial of SPONTAN for ED
LTR Pharma (ASX:LTP) has commenced patient recruitment for its Phase 2 pharmacokinetic study of SPONTAN, the company's rapid-acting intranasal spray for the treatment of erectile dysfunction, in Australia.